Quick Takeaways
- Et al Phillip Frost MD filed SCHEDULE 13D/A for Cocrystal Pharma, Inc. Common Stock, par value $0.001 per share (COCP).
- Disclosed ownership: 11%.
- Date of event: 30 Sep 2025.
Et al Phillip Frost MD - 30 Sep 2025 SCHEDULE 13D/A Report for Cocrystal Pharma, Inc. Common Stock, par value $0.001 per share (COCP)
- Filing Manager
- Et al Phillip Frost MD
- Reporting Manager
- Phillip Frost, M.D.
- Symbol
- COCP
- Shares outstanding
- 13,045,972 shares
- Disclosed Ownership
- 1,382,873 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13D/A
- Filing time
- 02 Oct 2025, 18:29:15 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 30 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Et al Phillip Frost MD disclosed 11% ownership in Cocrystal Pharma, Inc. Common Stock, par value $0.001 per share (COCP) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 02 Oct 2025, 18:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Phillip Frost, M.D. | 11% | 1,382,873 | 1,382,873 | 0 | /s/ Phillip Frost, M.D. | Phillip Frost, M.D. | 0000898860 |
| Frost Gamma Investments Trust | 10% | 1,319,838 | 1,319,838 | 0 | /s/ Phillip Frost, M.D. | Phillip Frost, M.D., Trustee | 0001380896 |